Physicians may be able to detect and treat Alzheimer’s Disease (AD) in its earliest stages, when patients are experiencing only mild degrees of cognitive impairment, thanks to new diagnostic criteria proposed by an international group of researchers.Published in Lancet Neurology, the development of new guidelines was co-led by Dr. Howard Feldman, head of the Div. of Neurology in the University of British Columbia’s Faculty of Medicine.
